COVAXIN phase-3 results show interim efficacy of 81%: Bharat Biotech releases data
Bharat Biotech announced the phase 3 results of its coronavirus vaccine ‘Covaxin’on Wednesday claiming the shots have demonstrated an interim clinical efficacy of nearly 81 per cent.
from Zee News :India National https://ift.tt/3kFHuMa
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments